These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
.
|
13-3115216
|
|
(State
of incorporation)
|
|
(IRS
Employer Identification Number)
|
|
3555
Veterans Memorial Highway, Suite C, Ronkonkoma, New
York
|
|
11779
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Large accelerated filer ☐
|
Accelerated filer
☑
|
|
Non-accelerated
filer ☐
|
Smaller reporting company ☐
|
|
Emerging
growth company ☐
|
|
|
Class
|
|
Outstanding
at December 13, 2018
|
|
Common
Stock, $0.01 par value per share
|
|
8,119,488
shares
|
|
Item
1.
Financial
Statements (Unaudited)
|
Page
|
|
|
|
|
|
|
|
Introduction
|
3
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Operations Three and Nine Months Ended
October 31, 2018 and 2017
|
4
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Comprehensive Income Three and Nine
Months Ended October 31, 2018 and 2017
|
5
|
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets October 31, 2018 and January 31,
2018
|
6
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows Nine Months Ended October 31,
2018 and 2017
|
7
|
|
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements
|
8
|
|
|
|
|
|
Item
2.
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
24
|
|
|
|
|
|
|
Item
3.
Quantitative and
Qualitative Disclosures about Market Risk
|
30
|
|
|
|
|
|
|
Item
4.
Controls and
Procedures
|
32
|
|
|
|
|
|
|
PART
II - OTHER INFORMATION:
|
|
|
|
|
|
|
|
Item
6.
Exhibits
|
33
|
|
|
|
|
|
|
Signature
Pages
|
34
|
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
Net
sales
|
$
24,009
|
$
23,960
|
$
73,970
|
$
70,831
|
|
Cost of goods
sold
|
15,691
|
14,907
|
46,995
|
44,530
|
|
Gross
profit
|
8,318
|
9,053
|
26,975
|
26,301
|
|
Operating
expenses
|
7,305
|
6,388
|
21,898
|
18,981
|
|
Operating
profit
|
1,013
|
2,665
|
5,077
|
7,320
|
|
Other income,
net
|
7
|
7
|
36
|
13
|
|
Interest
expense
|
(25
)
|
(35
)
|
(93
)
|
(147
)
|
|
Income
before taxes
|
995
|
2,637
|
5,020
|
7,186
|
|
Income tax
expense
|
494
|
831
|
1,634
|
1,828
|
|
Net
income
|
$
501
|
$
1,806
|
$
3,386
|
$
5,358
|
|
Net income per
common share:
|
|
|
|
|
|
Basic
|
$
0.06
|
$
0.23
|
$
0.42
|
$
0.72
|
|
Diluted
|
$
0.06
|
$
0.23
|
$
0.41
|
$
0.71
|
|
Weighted average
common shares outstanding:
|
|
|
|
|
|
Basic
|
8,119,488
|
7,894,582
|
8,117,307
|
7,477,202
|
|
Diluted
|
8,186,130
|
7,922,397
|
8,174,560
|
7,530,637
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
|
|
|
|
|
|
Net
income
|
$
501
|
$
1,806
|
$
3,386
|
$
5,358
|
|
Other comprehensive
income (loss):
|
|
|
|
|
|
Cash flow
hedges
|
-----
|
122
|
-----
|
(80
)
|
|
Foreign currency
translation adjustments
|
(235
)
|
(40
)
|
(860
)
|
292
|
|
Other comprehensive
income (loss)
|
(235
)
|
82
|
(860
)
|
212
|
|
Comprehensive
income
|
$
266
|
$
1,888
|
$
2,526
|
$
5,570
|
|
ASSETS
|
October
31,
|
January
31,
|
|
|
2018
|
2018
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
11,660
|
$
15,788
|
|
Accounts
receivable, net of allowance for doubtful accounts of $556 and $480
at October 31, 2018 and January 31, 2018, respectively
|
16,271
|
14,119
|
|
Inventories, net of
allowance of $2,222 and $2,422 at October 31, 2018 and January 31,
2018, respectively
|
46,620
|
42,919
|
|
Prepaid VAT
tax
|
1,971
|
2,119
|
|
Other current
assets
|
2,902
|
1,555
|
|
Total current
assets
|
79,424
|
76,500
|
|
Property and
equipment, net
|
10,286
|
8,789
|
|
Assets held for
sale
|
150
|
150
|
|
Deferred income
tax
|
7,205
|
7,557
|
|
Prepaid VAT and
other taxes
|
300
|
310
|
|
Other
assets
|
168
|
354
|
|
Goodwill
|
871
|
871
|
|
Total
assets
|
$
98,404
|
$
94,531
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Accounts
payable
|
$
7,687
|
$
6,855
|
|
Accrued
compensation and benefits
|
1,381
|
1,771
|
|
Other accrued
expenses
|
1,966
|
1,384
|
|
Current maturity of
long-term debt
|
158
|
158
|
|
Short-term
borrowings
|
179
|
211
|
|
Total current
liabilities
|
11,371
|
10,379
|
|
Long-term portion
of debt
|
1,200
|
1,312
|
|
Total
liabilities
|
12,571
|
11,691
|
|
Commitments and
contingencies
|
|
|
|
Stockholders’
equity
|
|
|
|
Preferred stock,
$0.01 par; authorized 1,500,000 shares (none issued)
|
-----
|
-----
|
|
Common stock, $0.01
par; authorized 20,000,000 and 10,000,000 shares at October 31,
2018 and January 31, 2018, respectively
; i
ssued 8,475,929 and
8,472,640 shares; outstanding 8,119,488 and 8,116,199 shares at
October 31, 2018 and January 31, 2018, respectively
|
85
|
85
|
|
Treasury stock, at
cost; 356,441 shares
|
(3,352
)
|
(3,352
)
|
|
Additional paid-in
capital
|
75,384
|
74,917
|
|
Retained
earnings
|
16,227
|
12,841
|
|
Accumulated other
comprehensive loss
|
(2,511
)
|
(1,651
)
|
|
Total stockholders'
equity
|
85,833
|
82,840
|
|
Total liabilities
and stockholders' equity
|
$
98,404
|
$
94,531
|
|
|
Nine Months
Ended
October
31,
|
|
|
|
2018
|
2017
|
|
Cash flows from
operating activities:
|
|
|
|
Net
income
|
$
3,386
|
$
5,358
|
|
Adjustments to
reconcile net income to net cash provided by (used in) operating
activities
|
|
|
|
Provision for
(recovery of) inventory obsolescence
|
(200
)
|
134
|
|
Provision for
(recovery of) doubtful accounts
|
76
|
(42
)
|
|
Deferred income
taxes
|
352
|
750
|
|
Depreciation and
amortization
|
642
|
582
|
|
Stock based and
restricted stock compensation
|
491
|
291
|
|
Loss on disposal of
property and equipment
|
14
|
-----
|
|
(Increase) decrease
in operating assets
|
|
|
|
Accounts
receivable
|
(2,655
)
|
(2,121
)
|
|
Inventories
|
(3,921
)
|
(2,953
)
|
|
Prepaid VAT
tax
|
148
|
(463
)
|
|
Other current
assets
|
(1,284
)
|
366
|
|
Increase (decrease)
in operating liabilities
|
|
|
|
Accounts
payable
|
1,019
|
3,576
|
|
Accrued expenses
and other liabilities
|
265
|
153
|
|
Net cash used by
the sale of Brazil
|
-----
|
(99
)
|
|
Net cash provided
by (used in) operating activities
|
(1,667
)
|
5,532
|
|
Cash flows from
investing activities:
|
|
|
|
Purchases of
property and equipment
|
(2,227
)
|
(619
)
|
|
Cash flows from
financing activities:
|
|
|
|
Net repayments
under revolving credit facility
|
-----
|
(4,865
)
|
|
Loan repayments,
short-term
|
(207
)
|
(867
)
|
|
Loan borrowings,
short-term
|
208
|
102
|
|
Loan repayments,
long-term
|
(118
)
|
(66
)
|
|
Loan borrowings,
long-term
|
-----
|
1,575
|
|
UK borrowings
(repayments) under line of credit facility, net
|
(11
)
|
538
|
|
Shares returned to
pay employee taxes under restricted stock program
|
-----
|
(376
)
|
|
Proceeds from
public offering, net of issuance costs of approximately $1.0
million
|
-----
|
10,113
|
|
Net cash provided
by (used in) financing activities
|
(128
)
|
6,154
|
|
Effect of exchange
rate changes on cash and cash equivalents
|
(106
)
|
61
|
|
Net increase
(decrease) in cash and cash equivalents
|
(4,128
)
|
11,128
|
|
Cash and cash
equivalents at beginning of period
|
15,788
|
10,365
|
|
Cash and cash
equivalents at end of period
|
$
11,660
|
$
21,493
|
|
|
|
|
|
Supplemental
disclosure of cash flow information:
|
|
|
|
Cash paid for
interest
|
$
93
|
$
147
|
|
Cash paid for
taxes
|
$
1,326
|
$
928
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
October
31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
External
Sales by geographic region:
|
|
|
|
|
|
USA
|
$
11.82
|
$
12.85
|
$
37.54
|
$
38.18
|
|
Other
foreign
|
4.41
|
4.39
|
13.60
|
12.47
|
|
Europe
(UK)
|
2.22
|
2.24
|
7.35
|
6.42
|
|
Mexico
|
0.77
|
0.51
|
2.70
|
1.66
|
|
China
|
4.79
|
3.97
|
12.78
|
12.10
|
|
Consolidated
external sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
|
Three Months Ended
October
31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
External
Sales by product lines:
|
|
|
|
|
|
Disposables
|
$
12.74
|
$
13.03
|
$
40.88
|
$
39.49
|
|
Chemical
|
4.74
|
3.98
|
12.42
|
10.53
|
|
Fire
|
1.02
|
1.27
|
3.57
|
4.52
|
|
Gloves
|
0.77
|
0.83
|
2.30
|
2.26
|
|
Hi-Vis
|
1.83
|
2.07
|
5.46
|
5.96
|
|
Wovens
|
2.91
|
2.78
|
9.34
|
8.07
|
|
Consolidated
external sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
|
October
31,
2018
|
January
31,
2018
|
|
|
|
|
|
Raw
materials
|
$
16,020
|
$
14,767
|
|
Work-in-process
|
1,750
|
2,357
|
|
Finished
goods
|
28,850
|
25,795
|
|
|
$
46,620
|
$
42,919
|
|
|
Short-Term
|
Long-term
|
Current Maturity of Long-term
|
|||
|
|
10/31/2018
|
1/31/2018
|
10/31/2018
|
1/31/2018
|
10/31/2018
|
1/31/2018
|
|
|
|
|
|
|
|
|
|
Argentina
|
$
32
|
$
31
|
$
-----
|
$
-----
|
$
-----
|
$
-----
|
|
UK
|
147
|
180
|
-----
|
-----
|
-----
|
-----
|
|
USA
|
-----
|
-----
|
1,200
|
1,312
|
158
|
158
|
|
Totals
|
$
179
|
$
211
|
$
1,200
|
$
1,312
|
$
158
|
$
158
|
|
|
Total
|
1
Year
or
less
|
2
Years
|
3
Years
|
4
Years
|
5
Years
|
After 5
Years
|
|
|
|
|
|
|
|
|
|
|
Borrowings in
USA
|
$
1,358
|
$
158
|
$
1,200
|
$
-----
|
$
----
|
$
-----
|
$
-----
|
|
Borrowing in
UK
|
147
|
147
|
-----
|
-----
|
-----
|
-----
|
-----
|
|
Borrowings in
Argentina
|
32
|
32
|
-----
|
-----
|
-----
|
-----
|
-----
|
|
Total
|
$
1,537
|
$
337
|
$
1,200
|
$
-----
|
$
----
|
$
-----
|
$
-----
|
|
|
Number of shares
awarded total
|
|||
|
|
Minimum
|
Target
|
Maximum
|
Cap
|
|
Employees
|
42,061
|
63,095
|
84,126
|
101,001
|
|
Non-employee
Directors
|
14,414
|
21,622
|
28,829
|
34,595
|
|
Total
|
56,475
|
84,717
|
112,955
|
135,596
|
|
|
Value at grant
date (numbers below are rounded to the nearest $100
|
|||
|
|
Minimum
|
Target
|
Maximum
|
Cap
|
|
Employees
|
$
583,600
|
$
875,400
|
$
1,167,200
|
$
1,401,300
|
|
Non-employee
Directors
|
200,000
|
300,000
|
400,000
|
480,000
|
|
Total
|
$
783,600
|
$
1,175,400
|
$
1,567,200
|
$
1,881,300
|
|
|
Three-Months
Ended
October
31,
|
Nine-Months
Ended
October
31,
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
2012
Plan
|
$
-----
|
$
-----
|
$
-----
|
$
206
|
|
2015
Plan
|
-----
|
-----
|
-----
|
197,284
|
|
2017
Plan
|
188,812
|
93,981
|
491,198
|
93,981
|
|
Total stock-based
compensation
|
$
188,812
|
$
93,981
|
$
491,198
|
$
291,471
|
|
Total income tax
benefit recognized for stock-based compensation
arrangements
|
$
39,651
|
$
33,833
|
$
103,152
|
$
104,929
|
|
Shares issued
under
2017 and 2015
Stock Plans
|
Outstanding
Unvested Grants at Maximum at Beginning of FY19
|
Granted
during
FY18 through
October 31, 2018
|
Becoming Vested
during FY18 through October 31, 2018
|
Forfeited
during
FY18 through
October 31, 2018
|
Outstanding
Unvested Grants at Maximum at End of
October 31,
2018
|
|
Restricted stock
grants – employees
|
42,291
|
41,835
|
-----
|
-----
|
84,126
|
|
Restricted stock
grants – non-employee directors
|
14,493
|
14,336
|
-----
|
-----
|
28,829
|
|
Retainer in stock
–
non-employee
directors
|
12,789
|
13,664
|
5,221
|
-----
|
21,232
|
|
Total restricted
stock
|
69,573
|
69,835
|
5,221
|
-----
|
$
134,187
|
|
|
|
|
|
|
|
|
Weighted average
grant date fair value
|
$
13.63
|
$
13.81
|
$
10.19
|
-----
|
$
13.85
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||
|
|
(in $000s except
share and per share information)
|
|||
|
|
2018
|
2017
|
2018
|
2017
|
|
Numerator:
|
|
|
|
|
|
Net
income
|
$
501
|
$
1,806
|
$
3,386
|
$
5,358
|
|
Denominator:
|
|
|
|
|
|
Denominator for
basic earnings per share
(weighted-average
shares which reflect 356,441 shares in the treasury)
|
8,119,448
|
7,894,582
|
8,117,307
|
7,477,202
|
|
Effect of dilutive
securities from restricted stock plan and from dilutive effect of
warrants
|
66,682
|
27,815
|
57,253
|
53,435
|
|
Denominator for
diluted earnings per share (adjusted weighted average
shares)
|
8,186,130
|
7,922,397
|
8,174,560
|
7,530,637
|
|
Basic earnings per
share
|
$
0.06
|
$
0.23
|
$
0.42
|
$
0.72
|
|
|
|
|
|
|
|
Diluted earnings
per share
|
$
0.06
|
$
0.23
|
$
0.41
|
$
0.71
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||||||
|
|
2018
|
2017
|
2018
|
2017
|
||||
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
$
11.82
|
49.24
%
|
$
12.85
|
53.64
%
|
$
37.54
|
50.75
%
|
$
38.18
|
53.91
%
|
|
International
|
12.19
|
50.76
%
|
11.11
|
46.36
%
|
36.43
|
49.25
%
|
32.65
|
46.09
%
|
|
Total
|
$
24.01
|
100.00
%
|
$
23.96
|
100.00
%
|
$
73.97
|
100.00
%
|
$
70.83
|
100.00
%
|
|
|
Three Months
Ended
October
31,
(in millions of
dollars)
|
Nine Months
Ended
October
31,
(in millions of
dollars)
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
Net
Sales:
|
|
|
|
|
|
USA
|
$
13.00
|
$
14.16
|
$
41.07
|
$
41.46
|
|
Other
foreign
|
5.74
|
4.94
|
16.71
|
13.66
|
|
Europe
(UK)
|
2.22
|
2.24
|
7.35
|
6.46
|
|
Mexico
|
1.15
|
0.90
|
3.83
|
2.77
|
|
China
|
12.05
|
13.47
|
39.55
|
36.88
|
|
Corporate
|
-----
|
0.45
|
0.75
|
0.98
|
|
Less intersegment
sales
|
(10.15
)
|
(12.20
)
|
(35.29
)
|
(31.38
)
|
|
Consolidated
sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
External
Sales:
|
|
|
|
|
|
USA
|
$
11.82
|
$
12.85
|
$
37.54
|
$
38.18
|
|
Other
foreign
|
4.41
|
4.39
|
13.60
|
12.47
|
|
Europe
(UK)
|
2.22
|
2.24
|
7.35
|
6.42
|
|
Mexico
|
0.77
|
0.51
|
2.70
|
1.66
|
|
China
|
4.79
|
3.97
|
12.78
|
12.10
|
|
Consolidated
external sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
Intersegment
Sales:
|
|
|
|
|
|
USA
|
$
1.18
|
$
1.31
|
$
3.53
|
$
3.28
|
|
Other
foreign
|
1.33
|
0.55
|
3.11
|
1.19
|
|
Europe
(UK)
|
-----
|
-----
|
----
|
0.04
|
|
Mexico
|
0.38
|
0.39
|
1.13
|
1.11
|
|
China
|
7.26
|
9.50
|
26.77
|
24.78
|
|
Corporate
|
-----
|
0.45
|
0.75
|
0.98
|
|
Consolidated
intersegment sales
|
$
10.15
|
$
12.20
|
$
35.29
|
$
31.38
|
|
Operating Profit
(Loss):
|
|
|
|
|
|
USA
|
$
1.66
|
$
2.62
|
$
6.45
|
$
7.40
|
|
Other
foreign
|
0.34
|
0.92
|
0.97
|
2.04
|
|
Europe
(UK)
|
0.03
|
(0.02
)
|
0.21
|
0.09
|
|
Mexico
|
(0.03
)
|
(0.06
)
|
0.17
|
(0.02
)
|
|
China
|
0.79
|
0.66
|
2.30
|
2.21
|
|
Corporate
|
(1.61
)
|
(1.46
)
|
(4.96
)
|
(4.56
)
|
|
Less intersegment
profit (loss)
|
(0.17
)
|
0.01
|
(0.06
)
|
0.16
|
|
Consolidated
operating profit
|
$
1.01
|
$
2.67
|
$
5.08
|
$
7.32
|
|
Depreciation and
Amortization Expense:
|
|
|
|
|
|
USA
|
$
0.03
|
$
0.03
|
$
0.09
|
$
0.09
|
|
Other
foreign
|
0.02
|
0.04
|
0.12
|
0.10
|
|
Europe
(UK)
|
-----
|
-----
|
0.01
|
0.01
|
|
Mexico
|
0.03
|
0.03
|
0.09
|
0.09
|
|
China
|
0.05
|
0.06
|
0.17
|
0.19
|
|
Corporate
|
0.09
|
0.05
|
0.19
|
0.14
|
|
Less
intersegment
|
-----
|
(0.01
)
|
(0.03
)
|
(0.04
)
|
|
Consolidated
depreciation & amortization expense
|
$
0.22
|
$
0.20
|
$
0.64
|
$
0.58
|
|
Interest
Expense:
|
|
|
|
|
|
Other
foreign
|
$
0.01
|
$
0.02
|
$
0.03
|
$
0.05
|
|
Europe
(UK)
|
-----
|
0.01
|
-----
|
0.01
|
|
Corporate
|
0.02
|
0.01
|
0.06
|
0.09
|
|
Consolidated
interest expense
|
$
0.03
|
$
0.04
|
$
0.09
|
$
0.15
|
|
Income Tax
Expense:
|
|
|
|
|
|
Other
foreign
|
$
0.17
|
$
0.16
|
$
0.37
|
0.42
|
|
Europe
(UK)
|
0.01
|
0.01
|
0.05
|
0.05
|
|
China
|
0.29
|
0.12
|
0.81
|
0.50
|
|
Corporate
|
0.05
|
0.55
|
0.39
|
0.83
|
|
Less
intersegment
|
(0.03
)
|
(0.01
)
|
0.01
|
0.03
|
|
Consolidated income
tax expense
|
$
0.49
|
$
0.83
|
$
1.63
|
$
1.83
|
|
|
Three Months
Ended
October
31,
(in millions of
dollars)
|
Nine Months
Ended
October
31,
(in millions of
dollars)
|
||
|
Capital
Expenditures:
|
2018
|
2017
|
2018
|
2017
|
|
USA
|
$
0.03
|
$
0.01
|
$
0.05
|
$
0.02
|
|
Other
Foreign
|
0.38
|
-----
|
1.09
|
-----
|
|
Mexico
|
0.09
|
0.03
|
0.20
|
0.06
|
|
China
|
0.02
|
0.01
|
0.05
|
0.07
|
|
India
|
(0.02
)
|
0.06
|
0.04
|
0.08
|
|
Corporate
|
0.51
|
0.06
|
0.80
|
0.39
|
|
Consolidated
capital expenditures
|
$
1.01
|
$
0.17
|
$
2.23
|
$
0.62
|
|
|
October
31,
2018
(in millions of
dollars)
|
January
31,
2018
(in millions of
dollars)
|
|
Total Assets:
*
|
|
|
|
USA
|
$
28.09
|
$
27.64
|
|
Other
foreign
|
25.30
|
20.30
|
|
Europe
(UK)
|
4.19
|
4.63
|
|
Mexico
|
5.14
|
4.69
|
|
China
|
35.23
|
31.59
|
|
India
|
(0.83
)
|
(0.85
)
|
|
Corporate
|
63.91
|
61.65
|
|
Less
intersegment
|
(62.63
)
|
(55.12
)
|
|
Consolidated
assets
|
$
98.40
|
$
94.53
|
|
Total Assets Less
Intersegment: *
|
|
|
|
USA
|
$
29.57
|
$
33.16
|
|
Other
foreign
|
17.55
|
12.61
|
|
Europe
(UK)
|
4.19
|
4.63
|
|
Mexico
|
5.25
|
4.84
|
|
China
|
18.57
|
16.97
|
|
India
|
1.10
|
0.98
|
|
Corporate
|
22.17
|
21.34
|
|
Consolidated
assets
|
$
98.40
|
$
94.53
|
|
Property and
Equipment (excluding assets held for sale at $0.2
million):
|
|
|
|
USA
|
$
1.95
|
$
1.99
|
|
Other
foreign
|
2.41
|
1.50
|
|
Europe
(UK)
|
0.01
|
0.03
|
|
Mexico
|
2.10
|
1.99
|
|
China
|
1.75
|
1.92
|
|
India
|
0.17
|
0.15
|
|
Corporate
|
1.84
|
1.18
|
|
Less
intersegment
|
0.06
|
0.03
|
|
Consolidated
property and equipment
|
$
10.29
|
$
8.79
|
|
Goodwill:
|
|
|
|
USA
|
$
0.87
|
$
0.87
|
|
Consolidated
goodwill
|
$
0.87
|
$
0.87
|
|
|
Three Months Ended
October
31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
External
Sales by geographic region:
|
|
|
|
|
|
USA
|
$
11.82
|
$
12.85
|
$
37.54
|
$
38.18
|
|
Other
foreign
|
4.41
|
4.39
|
13.60
|
12.47
|
|
Europe
(UK)
|
2.22
|
2.24
|
7.35
|
6.42
|
|
Mexico
|
0.77
|
0.51
|
2.70
|
1.66
|
|
China
|
4.79
|
3.97
|
12.78
|
12.10
|
|
Consolidated
external sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
|
Three Months Ended
October
31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2018
|
2017
|
2018
|
2017
|
|
External
Sales by product lines:
|
|
|
|
|
|
Disposables
|
$
12.74
|
$
13.03
|
$
40.88
|
$
39.49
|
|
Chemical
|
4.74
|
3.98
|
12.42
|
10.53
|
|
Fire
|
1.02
|
1.27
|
3.57
|
4.52
|
|
Gloves
|
0.77
|
0.83
|
2.30
|
2.26
|
|
Hi-Vis
|
1.83
|
2.07
|
5.46
|
5.96
|
|
Wovens
|
2.91
|
2.78
|
9.34
|
8.07
|
|
Consolidated
external sales
|
$
24.01
|
$
23.96
|
$
73.97
|
$
70.83
|
|
Employment
Agreement, dated November 5, 2018, between Teri W. Hunt and the
Company
|
|
31.1
*
|
Certification
of Chief Executive Officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
|
31.2
*
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1
*
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
|
|
32.2
*
|
Certification
of Chief Financial Officer pursuant to 18 U.S.C. Section 1350
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
101.INS
|
XBRL
instance Document
|
|
101.SCH
|
XBRL
Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL
Taxonomy Extension Definitions Document
|
|
101.DEF
|
XBRL
Taxonomy Extension Labels Document
|
|
101.LAB
|
XBRL
Taxonomy Extension Labels Document
|
|
101.PRE
|
XBRL
Taxonomy Extension Presentations Document
|
|
|
LAKELAND INDUSTRIES, INC.
(Registrant)
|
|
|
|
|
|
|
|
Date:
December 17, 2018
|
/s/ Christopher J.
Ryan
|
|
|
Christopher
J. Ryan,
Chief
Executive Officer, President and Secretary (Principal Executive
Officer and Authorized Signatory)
|
|
|
|
|
|
|
|
Date:
December 17, 2018
|
/s/ Teri W.
Hunt
|
|
|
Teri W.
Hunt,
Chief
Financial Officer(Principal Accounting Officer and Authorized
Signatory)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|